These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23923476)

  • 1. Methadone as an additional opioid for a cancer patient with severe neuropathic and bone pain not responsive to other opioids and adjuvant analgesics.
    Leppert W; Kowalski G
    J Palliat Care; 2013; 29(2):119-21. PubMed ID: 23923476
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric palliative care: use of opioids for the management of pain.
    Zernikow B; Michel E; Craig F; Anderson BJ
    Paediatr Drugs; 2009; 11(2):129-51. PubMed ID: 19301934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A successful switch from transdermal fentanyl to transdermal buprenorphine in a patient with neuropathic pain: a case report.
    Leppert W
    Am J Hosp Palliat Care; 2014 Feb; 31(1):101-4. PubMed ID: 23349342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
    Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
    J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of chronic neuropathic pain of different causes with the combination of oral methadone along with ketamine: A report of 18 cases.
    de Godoy MC; Dalmolin GD; Rigo FK; Rossato MF; de Menezes MS; Alvarez MA; Hernandes JJ; Moreno LA; Sinche M; Ferreira J
    Eur J Anaesthesiol; 2013 Oct; 30(10):638-40. PubMed ID: 23624745
    [No Abstract]   [Full Text] [Related]  

  • 8. Methadone for cancer pain: a case report.
    Nixon AJ
    Am J Hosp Palliat Care; 2005; 22(5):337. PubMed ID: 16225353
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of severe neuropathic cancer pain: an illustrative case and review.
    Connolly I; Zaleon C; Montagnini M
    Am J Hosp Palliat Care; 2013 Feb; 30(1):83-90. PubMed ID: 22504863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
    Müller-Busch HC; Lindena G; Tietze K; Woskanjan S
    Eur J Pain; 2005 Oct; 9(5):571-9. PubMed ID: 16139186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal buprenorphine in cancer pain and palliative care.
    Sittl R
    Palliat Med; 2006; 20 Suppl 1():s25-30. PubMed ID: 16764218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotating to oral methadone in advanced cancer patients: a case series.
    Kilonzo I; Twomey F
    J Palliat Med; 2013 Sep; 16(9):1154-7. PubMed ID: 23631611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine infusor pump switch to oral methadone.
    Santos Suárez J; Del Valle Arnáez G
    BMJ Support Palliat Care; 2020 Mar; 10(1):1-3. PubMed ID: 30944123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.
    Pergolizzi JV; Mercadante S; Echaburu AV; Van den Eynden B; Fragoso RM; Mordarski S; Lybaert W; Beniak J; Orońska A; Slama O;
    Curr Med Res Opin; 2009 Jun; 25(6):1517-28. PubMed ID: 19435402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is oral methadone better than placebo or other oral/transdermal opioids in the management of pain?
    Cherny N
    Palliat Med; 2011 Jul; 25(5):488-93. PubMed ID: 21708855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine to methadone conversion: an interpretation of published data.
    Pollock AB; Tegeler ML; Morgan V; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Mar; 28(2):135-40. PubMed ID: 20555039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients.
    Kannan TR; Saxena A; Bhatnagar S; Barry A
    J Pain Symptom Manage; 2002 Jan; 23(1):60-5. PubMed ID: 11779670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.